Halodine

Halodine, a Miami-based biopharmaceutical company, was founded with the core mission of developing novel antiviral therapies. The company's vision is to provide effective and accessible solutions to combat viral infections, particularly focusing on COVID-19. Halodine offers proprietary povidone-iodine antiseptic products, including the Halodine Nasal Antiseptic and Halodine Oral Rinse, designed for repeated nasal and oral administration. These products have been proven effective against SARS-CoV-2 and other infections, catering to hospitalized patients, healthcare personnel, and general consumers.

Notable affiliated people include leading clinicians who developed Halodine's proprietary formulations. The company has garnered attention from investors in the biopharmaceutical sector due to its innovative approach to antiviral protection. Key achievements include the proven efficacy of their products in killing 99.99% of the virus causing COVID-19 and providing up to 12-hour protection. Halodine's impact is significant in enhancing safety measures for both medical professionals and the public during the pandemic.